Global Melanoma Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516299
  • Report
  • Region: Global
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The researcher announced the results of its Melanoma patients study in a new research ‘Global Melanoma Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Melanoma epidemiology, Melanoma diagnosed patients, and Melanoma treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Melanoma derived from epidemiological analysis, patients diagnosed with Melanoma, and patients treated with a drug therapy.

The research study helps executives estimate Melanoma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Melanoma prevalence, Melanoma diagnosis rate, and Melanoma treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:
  • Melanoma Patient Flow
  • Melanoma Prevalence
  • Melanoma Diagnosed Patients
  • Melanoma Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Melanoma: Disease Definition
2. Global Melanoma Patient Flow
2A. Global Melanoma Prevalence
2B. Global Melanoma Diagnosed Patients
2C. Global Melanoma Treated Patients
3. Melanoma Patient Flow in the US
3A. Melanoma Prevalence in the US
3B. Melanoma Diagnosed Patients in the US
3C. Melanoma Treated Patients in the US
4. Melanoma Patient Flow in Europe
4A. Melanoma Prevalence in Europe
4B. Melanoma Diagnosed Patients in Europe
4C. Melanoma Treated Patients in Europe
5. Melanoma Patient Flow in Germany
5A. Melanoma Prevalence in Germany
5B. Melanoma Diagnosed Patients in Germany
5C. Melanoma Treated Patients in Germany
6. Melanoma Patient Flow in France
6A. Melanoma Prevalence in France
6B. Melanoma Diagnosed Patients in France
6C. Melanoma Treated Patients in France
7. Melanoma Patient Flow in Spain
7A. Melanoma Prevalence in Spain
7B. Melanoma Diagnosed Patients in Spain
7C. Melanoma Treated Patients in Spain
8. Melanoma Patient Flow in Italy
8A. Melanoma Prevalence in Italy
8B. Melanoma Diagnosed Patients in Italy
8C. Melanoma Treated Patients in Italy
9. Melanoma Patient Flow in UK
9A. Melanoma Prevalence in UK
9B. Melanoma Diagnosed Patients in UK
9C. Melanoma Treated Patients in UK
10. Melanoma Patient Flow in Japan
10A. Melanoma Prevalence in Japan
10B. Melanoma Diagnosed Patients in Japan
10C. Melanoma Treated Patients in Japan
11. Research Methodology

List of Tables
Table 1: Global Melanoma Patient Flow, 2017
Table 2: Global Melanoma Patient Flow Forecast, 2017 - 2026
Table 3: Melanoma Patient Flow in the US, 2017
Table 4: Melanoma Patient Flow Forecast in the US, 2017 - 2026
Table 5: Melanoma Patient Flow in Europe, 2017
Table 6: Melanoma Patient Flow Forecast in Europe, 2017 - 2026
Table 7: Melanoma Patient Flow in Germany, 2017
Table 8: Melanoma Patient Flow Forecast in Germany, 2017 - 2026
Table 9: Melanoma Patient Flow in France, 2017
Table 10: Melanoma Patient Flow Forecast in France, 2017 - 2026
Table 11: Melanoma Patient Flow in Spain, 2017
Table 12: Melanoma Patient Flow Forecast in Spain, 2017 - 2026
Table 13: Melanoma Patient Flow in Italy, 2017
Table 14: Melanoma Patient Flow Forecast in Italy, 2017 - 2026
Table 15: Melanoma Patient Flow in UK, 2017
Table 16: Melanoma Patient Flow Forecast in UK, 2017 - 2026
Table 17: Melanoma Patient Flow in Japan, 2017
Table 18: Melanoma Patient Flow Forecast in Japan, 2017 - 2026

List of Figures
Figures 1: Global Melanoma Patient Flow, 2017
Figure 2: Global Melanoma Patient Flow Forecast, 2017 - 2026
Figure 3: Melanoma Patient Flow in the US, 2017
Figure 4: Melanoma Patient Flow Forecast in the US, 2017 - 2026
Figure 5: Melanoma Patient Flow in Europe, 2017
Figure 6: Melanoma Patient Flow Forecast in Europe, 2017 - 2026
Figure 7: Melanoma Patient Flow in Germany, 2017
Figure 8: Melanoma Patient Flow Forecast in Germany, 2017 - 2026
Figure 9: Melanoma Patient Flow in France, 2017
Figure 10: Melanoma Patient Flow Forecast in France, 2017 - 2026
Figure 11: Melanoma Patient Flow in Spain, 2017
Figure 12: Melanoma Patient Flow Forecast in Spain, 2017 - 2026
Figure 13: Melanoma Patient Flow in Italy, 2017
Figure 14: Melanoma Patient Flow Forecast in Italy, 2017 - 2026
Figure 15: Melanoma Patient Flow in UK, 2017
Figure 16: Melanoma Patient Flow Forecast in UK, 2017 - 2026
Figure 17: Melanoma Patient Flow in Japan, 2017
Figure 18: Melanoma Patient Flow Forecast in Japan, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll